Overview
Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing
Status:
Recruiting
Recruiting
Trial end date:
2022-12-10
2022-12-10
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to explore the effectiveness and safety of umbilical cord blood mononuclear cells in promoting traumatic fracture healing.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Qianfoshan HospitalCollaborator:
Shandong Qilu Stem Cells Engineering Co., Ltd.
Criteria
Inclusion Criteria:- Traumatic long bone fracture.
- Noninfectious bone nonunion, delayed bone union.
- 3 months after the operation of the fracture, the examination showed no callus growth,
no signs of progressive repair at the fracture site, fracture piece space < 5mm.
- No shortening, angulation and displacement.
- There was no obvious callus growth 8 months after local bone grafting.
Exclusion Criteria:
- There are infection foci at and near the fracture end after fracture.
- 3 months after the fracture, tests showed partial callus growth.
- Combining shortening, angulation and displacement phenomena.
- Partial callus grew 8 months after local bone grafting.